Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: A systematic review
Authors:
- 1 August 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 13 (8) , 1125-1136
Abstract
University of Wisconsin (UW) solution has been recognized as the gold standard in liver preservation, but its limitations are becoming obvious, such as risk of biliary complications and its high cost. Alternatively, the effects of histidine‐tryptophan‐ketoglutarate (HTK), such as improved biliary protection and low cost, have been observed. This systematic review is conducted to compare the efficacy and safety of these 2 solutions. Databases from 1966 to June 2006 were searched. Randomized clinical trials (RCTs) and cohort studies comparing HTK and UW solutions for liver transplantation were included. Ten articles including 11 comparisons (1,200 patients) met the inclusion criteria, containing 2 RCTs and 9 cohort studies. No marked differences existed between the 2 groups in patient and graft survival rates, acute rejection, primary nonfunction, primary dysfunction, delayed graft function, and ALT and AST levels after transplantation. The only positive result was observed in the bile production after deceased donor liver transplantation (DDLT), which was statistically significantly higher in HTK group than that of UW group (95% confidence interval, 18.65‐57.47; P = 0.0001). Although the difference in biliary complications between the 2 groups did not reach statistical significance, HTK was thought to be more effective for biliary tract flush and prevention of biliary complications in some studies. There was no statistically significant difference of effects (except bile production) between HTK and UW. But trends were documented in some studies for the superiority of HTK in biliary tract flush, prevention of biliary complications, and cost saving. Adequately powered RCTs with longer follow‐up periods are required to evaluate the long‐term effect of these 2 solutions. Liver Transpl 13:1125–1136, 2007. © 2007 AASLD.Keywords
This publication has 34 references indexed in Scilit:
- CC chemokine receptor 5Δ32 polymorphism—a risk factor for ischemic-type biliary lesions following orthotopic liver transplantationLiver Transplantation, 2004
- Independent Predictors for Primary Non-Function after Liver TransplantationYonsei Medical Journal, 2004
- A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantationLiver Transplantation, 2003
- Decision for Retransplantation of the LiverAnnals of Surgery, 2002
- Long-term outcome of liver retransplantation in childrenTransplantation, 2002
- Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single centerTransplantation Proceedings, 2002
- Indications and results of retransplantation after a series of 406 consecutive liver transplantationsTransplantation Proceedings, 2002
- Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single CenterAnnals of Surgery, 2000
- Liver preservation: The past and the futureHepatology, 1991
- PRINCIPLES OF SOLID-ORGAN PRESERVATION BY COLD STORAGETransplantation, 1988